# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Hemingway (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET003-SYN-TD
- Date: 1955-03-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Walter Brandt-Ochoa, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Establishing primary care: heavy drinking, low mood and forgetfulness a year after two plane crashes, with high blood pressure and abnormal liver and iron tests on the intake panel. **S**

## Historical basis

- Ernest Hemingway was born on July 21, 1899, in Oak Park, Illinois, the son of a physician. **D**
- In the First World War he joined a volunteer ambulance unit in the Italian army; in 1918 he was wounded at the front near Fossalta di Piave by a mortar shell, was decorated by the Italian government, and spent a long time in hospitals. **D**
- He drank heavily for most of his adult life. **D**
- In January 1954, on a safari in Africa, he survived two plane crashes on consecutive days in Uganda. In the second he forced a jammed door open with his head and suffered a concussion and a skull fracture; he also reported a ruptured right kidney and injuries to his liver and spleen. The Nobel Prize biography records that the accidents caused severe pain for the rest of his life. **D**
- He was awarded the 1954 Nobel Prize in Literature and could not attend the ceremony in Stockholm because of ill health. **D**
- His home from 1939 to 1960 was Finca Vigía, a farm on a hillside outside Havana, Cuba, where he wrote much of his work. **D**
- His father, a physician who was described as depressed and diabetic, died by suicide in 1928. **D**
- Several earlier members of his family also had depression and died by suicide, and he understood himself to be descended from men who had died by suicide on both sides of his family. **D**

8 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He is afraid of losing his memory and his ability to write. **S**
- He wants to drink less without being told he must never drink again. **S**
- He worries about headaches and pain since the crashes. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Naltrexone 50 mg oral tablet, one tablet daily, to reduce heavy drinking **S**
- Thiamine 100 mg oral tablet, one tablet daily **S**
- Sertraline 50 mg oral tablet, one tablet daily **S**
- Amlodipine 5 mg oral tablet, one tablet daily **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1918: Wounded by a mortar shell near Fossalta di Piave while serving with an ambulance unit in Italy, with a long hospital stay **D** (CLM-0002)
- January 1954: Two plane crashes in Uganda on consecutive days: concussion and skull fracture, ruptured right kidney, and liver and spleen injuries, with lasting pain **D** (CLM-0004)
- by 1954: Heavy drinking for most of his adult life **D** (CLM-0003)

## Procedures and immunizations

- 1955-03-02 to 1955-03-02: Twelve-lead electrocardiogram at the diagnosis of hypertension: sinus rhythm at 86, normal intervals, borderline voltage for left ventricular hypertrophy **S**


## Family history

- father: Depression and diabetes; died by suicide in 1928 **D** (CLM-0007)

## Measurements

Hemoglobin: 15.6 g/dL; MCV: 102 fL (high); Platelets: 208 10*3/uL; Sodium: 138 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.98 mg/dL; eGFR (CKD-EPI 1950): 91 mL/min/1.73 m²; Glucose: 96 mg/dL; AST: 70 U/L (high); ALT: 78 U/L (high); GGT: 196 U/L (high); Total bilirubin: 1 mg/dL; Albumin: 4.1 g/dL; Serum iron: 214 ug/dL (high); Transferrin saturation: 76% (high); Ferritin: 1460 ng/mL (high); HbA1c: 6.1% (high); Total cholesterol: 214 mg/dL (high); LDL cholesterol: 118 mg/dL; HDL cholesterol: 52 mg/dL; Triglycerides: 236 mg/dL (high); TSH: 2.1 mIU/L; Vitamin B12: 412 pg/mL; Urine albumin-to-creatinine ratio: 14 mg/g; AUDIT: 26; PHQ-9: 16; MoCA: 25. All results are synthetic.

BP 152/94 mmHg; pulse 88 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 97% on room air; weight 98 kg; BMI 29.3 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, courteous and guarded at first, then direct; speech normal in rate; smells of alcohol at a late-morning visit without signs of intoxication or withdrawal; Mood low; PHQ-9 16 with item 9 scored 1; Mood Disorder Questionnaire negative; no psychotic features; passive thoughts that he would be better off dead on several days, without intent or plan; MoCA 25 of 30: lost points on delayed recall and serial sevens; oriented; language and visuospatial items normal. Functional status: Independent in all activities; back pain and stiffness since the crashes limit long walks; writing more slowly than before. Physical examination is intentionally limited. **S**

## Safety assessment

Current ideation: present; intent: absent; plan: absent; access reviewed: yes. Disposition: Outpatient care with close follow-up. C-SSRS screen: wish to be dead on several days in the past month; no active thoughts of suicide, intent, plan, preparation or past attempt. Risk factors reviewed without detail: a father who died by suicide, other deaths by suicide in his family, heavy drinking, depression, repeated head injuries, chronic pain, and firearms at home. Lethal-means counseling about firearms was done respectfully, as a hunter's safety question rather than a judgment: he chose to have his guns held in the locked storage at his shooting club while his mood and drinking are treated, and to keep no ammunition at home. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit. This is synthetic and does not convert historical behavior into a current finding. **S**

## Assessment

1. Alcohol use disorder, severe; heavy daily drinking for most of his adult life; synthetic modern episode linked to his documented heavy drinking; status draft. **S**
2. Raised transferrin saturation and ferritin found on routine intake tests, cause not yet known (heavy drinking, liver disease or iron overload); status draft. **S**
3. Major depressive disorder, single episode, moderate; Mood Disorder Questionnaire negative and no history of mania or hypomania; status draft. **S**
4. Essential hypertension, stage 2, with heavy drinking contributing; status draft. **S**
5. Post-concussion symptoms (headaches, slowed thinking and forgetfulness) after repeated head injuries, most recently a concussion with a skull fracture a year ago; chronic traumatic encephalopathy is not diagnosed; status draft. **S**
6. Prediabetes (HbA1c 6.1%); status draft. **S**

## Plan

- Alcohol: AUDIT and DSM-5-TR assessment, brief intervention in his own terms, naltrexone 50 mg daily, thiamine, a drinking diary, a goal he chooses and revisits, withdrawal precautions if he stops (no abrupt stop at his intake level without a plan), and mutual-help or counseling options offered. Guideline: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Hepatology consultation for raised iron studies and liver tests in a heavy drinker: to confirm the cause, stage the liver, and plan treatment. Guideline: Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases (2011); ACG Clinical Guideline: Hereditary Hemochromatosis (2019) **S**
- Depression: PHQ-9 at each visit, weekly psychotherapy (cognitive behavioral therapy) with the clinic's behavioral health clinician, sertraline, the Mood Disorder Questionnaire before the antidepressant, a structured safety assessment with a written safety plan, lethal-means counseling about firearms, the 988 Suicide & Crisis Lifeline, and safety review at every visit. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026) **S**
- Post-concussion symptoms: symptom-based care (headache plan without daily analgesics, sleep routine, graded activity, writing in shorter sessions), MoCA repeated after three months with less alcohol, no routine brain imaging without warning signs, and neuropsychological testing if thinking does not improve; chronic traumatic encephalopathy not diagnosed. Guideline: VA/DoD Clinical Practice Guideline for the Management and Rehabilitation of Post-Acute Mild Traumatic Brain Injury (2021) **S**
- Hypertension: home blood pressure monitoring, amlodipine, less alcohol and salt, ECG and urine albumin at diagnosis, echocardiogram for stage 2 hypertension, and a target below 130/80 mmHg. Guideline: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026) **S**
- Prediabetes: HbA1c repeated at six months, less alcohol, activity and diet; iron overload and alcohol both raise the risk of diabetes. Guideline: ACG Clinical Guideline: Hereditary Hemochromatosis (2019); Prediabetes and Type 2 Diabetes: Screening (2021) **S**

## Guideline basis

- Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases (2011), American Association for the Study of Liver Diseases (Hepatology 2011;54(1):328-343)
- ACG Clinical Guideline: Hereditary Hemochromatosis (2019), American College of Gastroenterology (Am J Gastroenterol 2019;114(8):1202-1218)
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018), American Psychiatric Association (Am J Psychiatry 2018;175(1):86-90)
- The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020), American Society of Addiction Medicine (Journal of Addiction Medicine)
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for the Management and Rehabilitation of Post-Acute Mild Traumatic Brain Injury (2021), United States Department of Veterans Affairs and Department of Defense
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017), American College of Cardiology and American Heart Association (Hypertension 2018;71(6):e13-e115)
- Prediabetes and Type 2 Diabetes: Screening (2021), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026), Aether Forge
